These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 34792181)

  • 1. CHA
    Jensen T; Thrane PG; Olesen KKW; Würtz M; Nielsen JC; Jensen LO; Madsen M; Thim T; Dalby Kristensen S; Lip GYH; Maeng M
    Eur J Clin Invest; 2022 Apr; 52(4):e13717. PubMed ID: 34792181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive value of CHA
    Sun Y; Ren J; Wang W; Wang C; Li L; Yao H
    Clin Cardiol; 2023 Aug; 46(8):950-957. PubMed ID: 37430484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of CHA
    Hjelholt TJ; Johnsen SP; Brynningsen PK; Pedersen AB
    J Am Geriatr Soc; 2020 Aug; 68(8):1698-1705. PubMed ID: 32294240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do physicians correctly calculate thromboembolic risk scores? A comparison of concordance between manual and computer-based calculation of CHADS2 and CHA2 DS2 -VASc scores.
    Esteve-Pastor MA; Marín F; Bertomeu-Martinez V; Roldán-Rabadán I; Cequier-Fillat Á; Badimon L; Muñiz-García J; Valdés M; Anguita-Sánchez M;
    Intern Med J; 2016 May; 46(5):583-9. PubMed ID: 26929032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CHA
    Mlodawska E; Tomaszuk-Kazberuk A; Lopatowska P; Kaminski M; Musial WJ
    Intern Med J; 2017 Mar; 47(3):275-279. PubMed ID: 27860070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithrombotic therapy in patients with non-valvular atrial fibrillation undergoing percutaneous coronary intervention: should we change our practice after the PIONEER AF-PCI and RE-DUAL PCI trials?
    Duerschmied D; Brachmann J; Darius H; Frey N; Katus HA; Rottbauer W; Schäfer A; Thiele H; Bode C; Zeymer U
    Clin Res Cardiol; 2018 Jul; 107(7):533-538. PubMed ID: 29679144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting stroke in patients without atrial fibrillation.
    Steensig K; Olesen KKW; Thim T; Nielsen JC; Madsen M; Jensen SE; Jensen LO; Kristensen SD; Lip GYH; Maeng M
    Eur J Clin Invest; 2019 Jun; 49(6):e13103. PubMed ID: 30883728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do CHA2 DS2 VASc and HAS-BLED scores influence 'real-world' anticoagulation management in atrial fibrillation? 1556 patient registry from the reference cardiology centre.
    Lopatowska P; Tomaszuk-Kazberuk A; Mlodawska E; Bachorzewska-Gajewska H; Malyszko J; Dobrzycki S; Musial WJ
    Pharmacoepidemiol Drug Saf; 2015 Dec; 24(12):1297-303. PubMed ID: 26419506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Refinement of ischemic stroke risk in patients with atrial fibrillation and CHA2 DS2 -VASc score of 1.
    Huang D; Anguo L; Yue WS; Yin L; Tse HF; Siu CW
    Pacing Clin Electrophysiol; 2014 Nov; 37(11):1442-7. PubMed ID: 25039724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral anticoagulation after catheter ablation of atrial fibrillation and the associated risk of thromboembolic events and intracranial hemorrhage: A systematic review and meta-analysis.
    Romero J; Cerrud-Rodriguez RC; Diaz JC; Rodriguez D; Arshad S; Alviz I; Cerna L; Rios S; Monhanty S; Natale A; Garcia MJ; Di Biase L
    J Cardiovasc Electrophysiol; 2019 Aug; 30(8):1250-1257. PubMed ID: 31257677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of percutaneous left atrial appendage closure with the Amplatzer cardiac plug in patients with atrial fibrillation and contraindications to anticoagulation.
    Wiebe J; Bertog S; Franke J; Wettstein O; Lehn K; Hofmann I; Vaskelyte L; Sievert H
    Catheter Cardiovasc Interv; 2014 Apr; 83(5):796-802. PubMed ID: 24327462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between cardiac rhythm, left atrial appendage flow velocity, and CHA
    Zuo K; Sun L; Yang X; Lyu X; Li K
    Clin Cardiol; 2017 Feb; 40(2):120-125. PubMed ID: 28075503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Augmented intelligence decision tool for stroke prediction combines factors from CHA
    Horne BD; Jacobs V; May HT; Graves KG; Bunch TJ
    J Cardiovasc Electrophysiol; 2019 Sep; 30(9):1452-1461. PubMed ID: 31115939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Triple Therapy in Patients With Non-Valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention Regarding Thromboembolic Risk Stratification.
    Sambola A; Mutuberría M; García Del Blanco B; Alonso A; Barrabés JA; Alfonso F; Bueno H; Cequier A; Zueco J; Rodríguez-Leor O; Bosch E; Tornos P; García-Dorado D
    Circ J; 2016; 80(2):354-62. PubMed ID: 26725763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The co-predictive value of a cardiovascular score for CV outcomes in diabetic patients with no atrial fibrillation.
    Patti G; Sticchi A; Pasceri V; Ricci F; Renda G; Hamrefors V; Melander O; Sutton R; Engström G; De Caterina R; Fedorowski A
    Diabetes Metab Res Rev; 2019 Jul; 35(5):e3145. PubMed ID: 30790434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CHA
    Su CH; Tsao TF; Chen AC; Chang KW; Yang YS; Ueng KC; Tsai CF
    Eur J Clin Invest; 2018 Mar; 48(3):. PubMed ID: 29288496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Burden of atrial fibrillation: a retrospective review of patients presenting to acute medical services.
    Jolliffe E; Fu V; Lanford J; Weatherall M; Rosemergy I
    Intern Med J; 2016 Oct; 46(10):1166-1171. PubMed ID: 27501863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of GRACE and CHA2DS2-VASc score among patients with atrial fibrillation undergoing percutaneous coronary intervention.
    Guo T; Xi Z; Qiu H; Wang Y; Zheng J; Dou K; Xu B; Qiao S; Yang W; Gao R
    Ann Med; 2021 Dec; 53(1):2215-2224. PubMed ID: 34791980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive accuracy of CHA2DS2-VASc and HAS-BLED scores in patients without atrial fibrillation undergoing percutaneous coronary intervention and discharged on dual antiplatelet therapy.
    Capodanno D; Rossini R; Musumeci G; Lettieri C; Senni M; Valsecchi O; Angiolillo DJ; Lip GY
    Int J Cardiol; 2015 Nov; 199():319-25. PubMed ID: 26241637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CHA2DS2-VASc and R2CHA2DS2-VASc scores predict mortality in high cardiovascular risk population.
    D'Errico MM; Piscitelli P; Mirijello A; Santoliquido M; Salvatori M; Vigna C; Vendemiale G; Lamacchia O; Fontana A; Copetti M; Pontremoli R; De Cosmo SA
    Eur J Clin Invest; 2022 Nov; 52(11):e13830. PubMed ID: 35778894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.